Skip to content
lifestyle.easyhouseremodeling.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Helus Pharma
Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering
June 25, 2026
Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress
June 24, 2026
Helus Pharma™ Announces US$50 Million Underwritten Offering
June 24, 2026
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference
April 30, 2026
Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
April 23, 2026
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
April 20, 2026
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
April 16, 2026
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer
March 13, 2026
Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder
March 12, 2026
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
March 10, 2026
1
2
Next Page
→